Biotechnology

The Biotechnology team at KTN focuses on Industrial Biotechnology (IB), Engineering Biology (EB, commonly referred to as Synthetic Biology) and Microbiomes.

Biotechnology

These technologies have the potential to carry out transformations which would not be feasible, technically or economically, using traditional chemistry. They hold the potential to make entirely new materials or to develop processes which run at low or ambient temperatures, thus reducing energy consumption. Consequently they can have a major impact in the UK’s move to Net Zero emissions.

The team works with all sectors that either use, or are interested in using, biotechnology in their business, in particular Chemicals, Pharmaceuticals, Home & Personal Care, AgroChemicals, Food and Drink – and many more.

Our experts use deep knowledge of the sector to help you and your business innovate through access to funding, expertise and building connections and collaborations. The team works closely with national bodies such as the Industrial Biotechnology Leadership Forum (IBLF) and the Engineering Biology Leadership Council (EBLC).

Follow us on Twitter: @KTN_Biotech

Our current focus in this area

Engineering Biology (EngBio) provides us with the opportunity to step away from traditional methods and provide innovative solutions for challenges brought by climate change and the associated impact areas, like food availability and the need for sustainable feedstocks.

Similar to Engineering Biology, Industrial Biotech impacts numerous sectors including Chemistry, Materials, Healthcare and AgriFood. It also has a significant role in the development of a Circular Economy by using waste as a feedstock for biobased products.

The Microbiome Innovation Network (formerly SIG) aims to accelerate the commercialisation of microbiome-based products and services in the UK and create a vibrant community by connecting industry and academia.

Current Biotechnology funding opportunities

DASA Competition: Engineering Biology for Defence and Security

Opens: 20/06/2022 Closes: 25/08/2022

Dstl is seeking highly innovative approaches to understand the contribution that engineering biology can make to Defence Capability in materials, power, energy and sensing.

More Information

Biomedical Catalyst 2022 Round 2: Industry-led R&D

Opens: 15/08/2022 Closes: 12/10/2022

UK registered SMEs can apply for a share of up to £25 million to develop innovative solutions to health and healthcare challenges.

More Information

2022 CRACK IT Challenges - replacing, reducing and improving animal testing

Opens: 08/09/2022 Closes: 03/10/2022

Funding of £1.2M is available through the 2022 CRACK IT Challenges competition to solve two Challenges: “Animal-free tumourigenicity assessment of CAR-T and other genetically modified T cells” and “Development of an in silico model to predict thyroid receptor mediated human endocr

More Information

Related Events and Recordings

Thu
24
Feb
2022

Approaches to Life Cycle Assessment in the Bioeconomy

10.00 - 11.30 | Online

Watch Now
Thu
5
May
2022

Transforming local bio-based waste streams into circular textile and building materials

10.00 - 12.00 | Online

Watch Now
Wed
13
Jul
2022

Bacteriophages as Alternative Antimicrobials

10.00 - 12.00 | Online

Watch now
See all events

Our Experts

Related News

Opportunities in the Circular Bio-based Europe Joint Undertaking (CBE JU)

05/08/2022

Opportunities in the Circular Bio-based Europe Joint Undertaking (CBE JU)

The Circular Bio-based Europe Joint Undertaking (CBE JU) is a new €2 billion partnership between the European Union and the Bio-based Industries Consortium (BIC) that funds projects advancing competitive circular bio-based industries in Europe. There are currently twelve available open calls with a deadline of 22 September 2022.

Read more
Forgotten Foods UK Research Expertise and Capabilities Database

29/07/2022

Forgotten Foods UK Research Expertise and Capabilities Database

Forgotten foods describe crops that haven’t attracted sufficient research, development, and commercial attention.

Read more
More News

For general enquiries regarding our Biotechnology sector contact us now